Extended Data Fig. 2: A consort style diagram of patient cohorts.
From: Combined PD-1, BRAF and MEK inhibition in BRAFV600E colorectal cancer: a phase 2 trial

a consort style diagram of patient cohorts.
From: Combined PD-1, BRAF and MEK inhibition in BRAFV600E colorectal cancer: a phase 2 trial
a consort style diagram of patient cohorts.